Belgium’s Tigenix says heart attack stem cell trial successful … – Business Insider
Business Insider |
Belgium's Tigenix says heart attack stem cell trial successful …
Business Insider BRUSSELS (Reuters) – Belgian biotech group Tigenix said on Monday its medical trial with a novel treatment for patients at risk of heart failure after a coronary … New Cardiac Stem Cell Therapy passes Phase I/II Trials |
